Eli Lilly to acquire manufacturing facility from Nexus Pharma [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Lilly expects production at the facility based in Pleasant Prairie, Wisconsin, to begin at the end of 2025. WHY IT'S IMPORTANT Soaring demand for GLP-1 agonists, a class of highly effective diabetes and obesity drugs which suppress appetite and promote a feeling of fullness, has led to constrained supply for drugmakers such as Lilly and Danish drugmaker Novo Nordisk . Last week, the U.S. Food and Drug Administration's website showed that due to increased demand, most doses of Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year. Larger doses of injectable medicines Mounjaro and Zepbound, including the 5 milligrams (mg), 7.5 mg, 10 mg, 12.5 mg, and 15 mg versions, had limited availability, according to the FDA website. The 2.5-milligram dose for the treatments was listed as available. Lilly had said it anticipates limited availability in the near term but had signaled that investments in manufacturing
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Weight-loss drug competition heats up. Is Wegovy in trouble? [Yahoo! Finance]Yahoo! Finance
- Weight-loss drug competition heats up. Is Wegovy in trouble? [Yahoo! Finance Canada]Yahoo! Finance Canada
- Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide [CNBC]CNBC
- FTC Moves to Allow Generic Versions of Ozempic [Yahoo! Finance]Yahoo! Finance
- Wegovy maker Novo Nordisk down 4%, heads for worst day since October [CNBC]CNBC
NVO
Earnings
- 5/2/24 - Beat
NVO
Sec Filings
- 5/2/24 - Form 6-K
- 5/1/24 - Form 6-K
- 4/26/24 - Form 6-K
- NVO's page on the SEC website